Wellcome Trust establishes first translational partnership in Germany with Charité and the BIH

Charité – Universitätsmedizin Berlin and the Berlin Institute of Health (BIH) are the first institutions in Germany to receive funding to create a translational partnership with the UK-based Wellcome Trust. Via its translational partnerships, the Wellcome Trust supports institutions in…

Wellcome Trust establishes first translational partnership in Germany with Charité and the BIH

Charité – Universitätsmedizin Berlin and the Berlin Institute of Health (BIH) are the first institutions in Germany to receive funding to create a translational partnership with the UK-based Wellcome Trust. Via its translational partnerships, the Wellcome Trust supports institutions in…

Simulations suggest embryo selection based on traits like height or IQ is still far off

There have been concerns about the idea of “designer babies” for almost as long as in vitro fertilization and technology to screen embryos for inherited disorders have existed. While the recent live births resulting from human embryonic CRISPR editing have…

Simulations suggest embryo selection based on traits like height or IQ is still far off

There have been concerns about the idea of “designer babies” for almost as long as in vitro fertilization and technology to screen embryos for inherited disorders have existed. While the recent live births resulting from human embryonic CRISPR editing have…

‘Combo’ nanoplatforms for chemotherapy

In a paper to be published in the forthcoming issue in NANO , researchers from Harbin Institute of Technology, China have systematically discussed the recent progresses, current challenges and future perspectives of smart graphene-based nanoplatforms for synergistic tumor therapy and…

New nonprofit organization formed to accelerate drug development in autism-associated genetic conditions

LOS ANGELES, CA, October 23, 2019 – Parents of children affected by Phelan-McDermid syndrome (PMS) announce the formation of CureSHANK, a nonprofit organization to accelerate drug development in PMS and other diseases related to the SHANK genes. As one of…

By cutting out one gene, researchers remove a tadpole’s ability to regenerate

Tadpoles of frogs that can typically regrow amputated tails or limbs lost their ability to regenerate after researchers blocked the expression of a newly identified gene that is one of the drivers for this regrowth. Furthermore, scientists hypothesize that the…

Beverly Davidson, PhD, Elected to the National Academy of Medicine

Beverly L. Davidson, PhD, director of the Raymond G. Perelman Center for Cellular and Molecular Therapeutics at Children’s Hospital of Philadelphia, has been elected to the National Academy of Medicine. She is being recognized for her role in developing innovative therapies for fatal, inherited brain disorders.